These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 19374970

  • 1. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH, Lee YS, Na C, Ahn JY, Chung US, Daniels MA, Haws CA, Renshaw PF.
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [Abstract] [Full Text] [Related]

  • 2. Attention deficit hyperactivity symptoms and internet addiction.
    Yoo HJ, Cho SC, Ha J, Yune SK, Kim SJ, Hwang J, Chung A, Sung YH, Lyoo IK.
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):487-94. PubMed ID: 15482579
    [Abstract] [Full Text] [Related]

  • 3. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 4. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I, Türkbay T, Cöngöloğlu A.
    Turk Psikiyatri Derg; 2008 Jan; 19(4):358-64. PubMed ID: 19110977
    [Abstract] [Full Text] [Related]

  • 5. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
    Johnson KA, Barry E, Bellgrove MA, Cox M, Kelly SP, Dáibhis A, Daly M, Keavey M, Watchorn A, Fitzgerald M, McNicholas F, Kirley A, Robertson IH, Gill M.
    Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
    [Abstract] [Full Text] [Related]

  • 6. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.
    Cheon KA, Cho DY, Koo MS, Song DH, Namkoong K.
    Biol Psychiatry; 2009 Apr 01; 65(7):564-70. PubMed ID: 19150055
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131
    [Abstract] [Full Text] [Related]

  • 8. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 30; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T.
    Biol Psychiatry; 2006 May 01; 59(9):829-35. PubMed ID: 16373066
    [Abstract] [Full Text] [Related]

  • 10. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA.
    Arch Gen Psychiatry; 2007 Feb 01; 64(2):218-24. PubMed ID: 17283289
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS, Chao CC, Wu YY, Chen YY, Chen CK.
    Psychiatry Clin Neurosci; 2007 Jun 01; 61(3):219-25. PubMed ID: 17472588
    [Abstract] [Full Text] [Related]

  • 12. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
    Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M.
    J Am Acad Child Adolesc Psychiatry; 2003 Apr 01; 42(4):424-33. PubMed ID: 12649629
    [Abstract] [Full Text] [Related]

  • 13. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.
    Ozdag MF, Yorbik O, Ulas UH, Hamamcioglu K, Vural O.
    Int J Pediatr Otorhinolaryngol; 2004 Oct 01; 68(10):1267-72. PubMed ID: 15364497
    [Abstract] [Full Text] [Related]

  • 14. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
    Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE.
    Can J Clin Pharmacol; 2006 Oct 01; 13(1):e50-62. PubMed ID: 16456216
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.
    Clin Neuropharmacol; 2009 Oct 01; 32(4):179-82. PubMed ID: 19644227
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 01; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 17. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder.
    Cheon KA, Jun JY, Cho DY.
    Int Clin Psychopharmacol; 2008 Sep 01; 23(5):291-8. PubMed ID: 18703939
    [Abstract] [Full Text] [Related]

  • 18. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.
    Toxicol Lett; 2009 Jan 10; 184(1):38-43. PubMed ID: 19015014
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
    Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L, Adult ADHD Research Group.
    Biol Psychiatry; 2007 Jun 15; 61(12):1380-7. PubMed ID: 17137560
    [Abstract] [Full Text] [Related]

  • 20. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P, Hsu HY, Chiou SS, Chao MC.
    Aust N Z J Psychiatry; 2007 Dec 15; 41(12):998-1004. PubMed ID: 17999272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.